Tara Cochrane

17PUBLICATIONS

87CO-AUTHORS

Language documentation and descriptionHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical infection agents (incl. prions)Respiratory diseases

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (17)

Sort by Publication Date:

|Jul 07, 2026

Australasian chronic lymphocytic leukaemia consensus statement: 2026 update.

|Apr 02, 2025

Establishing best practice in the Australian haematology setting for the use of chimeric antigen receptor T-cell therapy for relapsed and refractory lymphoma.

Michael Dickinson, Nicole O'Leary, Nada Hamad

|Sep 03, 2024

Ibrutinib plus rituximab and mini-CHOP in older patients with newly diagnosed DLBCL: a phase 2 ALLG study.

Emma Verner, Amanda Johnston, Nalini Pati

|Aug 19, 2024

Sequential high-dose methotrexate and cytarabine administration improves outcomes in real-world patients with primary central nervous system lymphoma: A report from the Australasian Lymphoma Alliance.

Maciej Tatarczuch, Katharine Louise Lewis, Ashray Gunjur

|Jul 08, 2024

Australians with chronic lymphocytic leukaemia continue to have high rates of second primary malignancies in the modern era.

Diva Baggio, Eliza Chung, Cameron Wellard

|Apr 18, 2024

Poor outcomes for trial-ineligible patients receiving polatuzumab for relapsed/refractory diffuse large B-cell lymphoma in routine care: An Australian Lymphoma and Related Diseases Registry project.

Briony Shaw, Eliza Chung, Cameron Wellard

Pageof 3

Frequent Collaborators

Nada Hamad

Eliza Hawkes

Chan Yoon Cheah

Judith Trotman

Michael Dickinson

Dipti Talaulikar

Rory Bennett

Pietro R Di Ciaccio

Robert Weinkove

Mary Ann Anderson

Frequent Collaborators

Nada Hamad

Eliza Hawkes

Chan Yoon Cheah

Judith Trotman